VYEPTI (eptinezumab-jjmr) is the first and only FDA-approved IV treatment for migraine prevention in adults. Just one 30-minute IV infusion 4x a year (every 3 months) can result in less migraine days a month for most patients.

Please consult your physician to see if this new medication is an option for you. Birmingham Infusion Center will precert the insurance for our patients and manage their treatment plan in a safe comfortable setting.